BioSpace News Archive

Pharm Country

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Verdant Health in Pennsylvania

Verdant Health is implementing a non-invasive and drug free solution for Erectile Dysfunction called GAINSWave, which boasts a 75% success rate.

February 18, 2019

·

2 min read

Business

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Elite Medical Center in Georgia

Elite Medical Center is implementing a non-invasive and drug free solution for Erectile Dysfunction called GAINSWave, which boasts a 75% success rate.

February 18, 2019

·

2 min read

National Social Art Forum - Serving youth homelessness

On February 22 and 23, 2019, the Musée national des beaux-arts du Québec will host the National Social Art Forum.

February 18, 2019

·

3 min read

Business

Sleep-deprived Americans Should Check Out Peroxfarma’s Epaplus Sleepcare Supplements

Restless nights falling asleep are a common problem for many people.

February 18, 2019

·

2 min read

Business

Lotta Ferm Appointed as Interim CFO at Medivir

Medivir AB as previously announced, Erik Björk will leave the role as Medivir’s CFO. Lotta Ferm will assume the role as interim CFO as of March 1st.

February 18, 2019

·

1 min read

Business

Candy Head: Research Suggests CBD Oil May Help Americans Who Suffer From Anxiety

Candy Head’s full-spectrum infused CBD edibles may be able to help the more than 40 million adults who suffer from anxiety in the United States.

February 18, 2019

·

1 min read

Philips launches Zenition mobile C-arm platform for enhanced operating room performance and workflow efficiency

Major advances pioneered on the Philips Azurion image-guided therapy platform now brought to mobile C-arm systems

February 18, 2019

·

5 min read

Business

Oncopeptides Will Host a Webcast in Conjunction With its Year-end Report 2018 on 22 February at 14.00 (CET)

Oncopeptides AB announces that the Company will release its Year-end Report on 22 February at 8:00 am CET.

February 18, 2019

·

1 min read

Drug Development

Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder Trial Shows the Potential for Significant Patient Benefit When Drug Exposure Is Adequate

Bionomics Limited announces that an additional data analysis conducted in Sweden by Pharmetheus AB showed a statistically significant response when drug exposure versus response was measured in the Phase 2 PTSD Trial.

February 18, 2019

·

6 min read

Business

Inflazome Appoints Prof. Marco Colonna M.D. to Its Scientific Advisory Board

Distinguished scientist with deep expertise in innate immunity and its role in neurodegenerative diseases

February 18, 2019

·

4 min read